Influence of transfusions, hemodialysis and extracorporeal life support on hyperferritinemia in critically ill patients.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2021
2021
Historique:
received:
23
02
2021
accepted:
25
06
2021
entrez:
12
7
2021
pubmed:
13
7
2021
medline:
17
11
2021
Statut:
epublish
Résumé
Ferritin is the major iron storage protein and an acute phase reactant. Hyperferritinemia is frequently seen in the critically ill where it has been hypothesized that not only underlying conditions but also factors such as transfusions, hemodialysis and extracorporeal life support (ECLS) lead to hyperferritinemia. This study aims to investigate the influence of transfusions, hemodialysis, and ECLS on hyperferritinemia in a multidisciplinary ICU cohort. This is a post-hoc analysis of a retrospective observational study including patients aged ≥ 18 years who were admitted to at least one adult ICU between January 2006 and August 2018 with hyperferritinemia ≥ 500 μg/L and of ≥ 14 days between two ICU ferritin measurements. Patients with hemophagocytic lymphohistiocytosis (HLH) were excluded. To identify the influence of transfusions, hemodialysis, and ECLS on ferritin change, multivariable linear regression analysis with ferritin change between two measurements as dependent variable was performed. A total of 268 patients was analyzed. Median duration between measurements was 36 days (22-57). Over all patients, ferritin significantly increased between the first and last measurement (p = 0.006). Multivariable linear regression analysis showed no effect of transfusions, hemodialysis, or ECLS on ferritin change. Changes in aspartate aminotransferase (ASAT) and sequential organ failure assessment (SOFA) score were identified as influencing factors on ferritin change [unstandardized regression coefficient (B) = 2.6; (95% confidence interval (CI) 1.9, 3.3); p < 0.001 and B = 376.5; (95% CI 113.8, 639.1); p = 0.005, respectively]. Using the same model for subgroups of SOFA score, we found SOFA platelet count to be associated with ferritin change [B = 1729.3; (95% CI 466.8, 2991.9); p = 0.007]. No association of ferritin change and in-hospital mortality was seen in multivariable analysis. The present study demonstrates that transfusions, hemodialysis, and ECLS had no influence on ferritin increases in critically ill patients. Hyperferritinemia appears to be less the result of iatrogenic influences in the ICU thereby underscoring its unskewed diagnostic value. The study was registered with www.ClinicalTrials.gov (NCT02854943) on August 1, 2016.
Sections du résumé
BACKGROUND
Ferritin is the major iron storage protein and an acute phase reactant. Hyperferritinemia is frequently seen in the critically ill where it has been hypothesized that not only underlying conditions but also factors such as transfusions, hemodialysis and extracorporeal life support (ECLS) lead to hyperferritinemia. This study aims to investigate the influence of transfusions, hemodialysis, and ECLS on hyperferritinemia in a multidisciplinary ICU cohort.
METHODS
This is a post-hoc analysis of a retrospective observational study including patients aged ≥ 18 years who were admitted to at least one adult ICU between January 2006 and August 2018 with hyperferritinemia ≥ 500 μg/L and of ≥ 14 days between two ICU ferritin measurements. Patients with hemophagocytic lymphohistiocytosis (HLH) were excluded. To identify the influence of transfusions, hemodialysis, and ECLS on ferritin change, multivariable linear regression analysis with ferritin change between two measurements as dependent variable was performed.
RESULTS
A total of 268 patients was analyzed. Median duration between measurements was 36 days (22-57). Over all patients, ferritin significantly increased between the first and last measurement (p = 0.006). Multivariable linear regression analysis showed no effect of transfusions, hemodialysis, or ECLS on ferritin change. Changes in aspartate aminotransferase (ASAT) and sequential organ failure assessment (SOFA) score were identified as influencing factors on ferritin change [unstandardized regression coefficient (B) = 2.6; (95% confidence interval (CI) 1.9, 3.3); p < 0.001 and B = 376.5; (95% CI 113.8, 639.1); p = 0.005, respectively]. Using the same model for subgroups of SOFA score, we found SOFA platelet count to be associated with ferritin change [B = 1729.3; (95% CI 466.8, 2991.9); p = 0.007]. No association of ferritin change and in-hospital mortality was seen in multivariable analysis.
CONCLUSIONS
The present study demonstrates that transfusions, hemodialysis, and ECLS had no influence on ferritin increases in critically ill patients. Hyperferritinemia appears to be less the result of iatrogenic influences in the ICU thereby underscoring its unskewed diagnostic value.
TRIAL REGISTRATION
The study was registered with www.ClinicalTrials.gov (NCT02854943) on August 1, 2016.
Identifiants
pubmed: 34252125
doi: 10.1371/journal.pone.0254345
pii: PONE-D-21-06136
pmc: PMC8274924
doi:
Substances chimiques
Ferritins
9007-73-2
Banques de données
ClinicalTrials.gov
['NCT02854943']
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0254345Déclaration de conflit d'intérêts
The authors declare no competing interests.
Références
Blood. 2009 Nov 19;114(21):4632-8
pubmed: 19721013
North Clin Istanb. 2015 Dec 31;2(3):189-195
pubmed: 28058366
Blood. 2015 Mar 5;125(10):1548-52
pubmed: 25573993
Transfusion. 1992 Oct;32(8):764-5
pubmed: 1412686
Crit Care. 2016 Nov 28;20(1):387
pubmed: 27890016
Blood Rev. 2009 May;23(3):95-104
pubmed: 18835072
Hepat Med. 2016 Apr 15;8:39-50
pubmed: 27186144
Pediatr Blood Cancer. 2007 Feb;48(2):124-31
pubmed: 16937360
Transfusion. 2019 Apr;59(4):1196-1201
pubmed: 30597563
Haematologica. 2019 Feb;104(2):e51-e53
pubmed: 30213831
Aging Clin Exp Res. 2019 Dec;31(12):1727-1734
pubmed: 30707355
N Engl J Med. 2012 Jan 26;366(4):348-59
pubmed: 22276824
Am J Clin Pathol. 2016 May;145(5):646-50
pubmed: 27247369
Nephrol Dial Transplant. 2000 Jun;15(6):883-7
pubmed: 10831646
Crit Care. 2020 May 24;24(1):244
pubmed: 32448380
Medicina (Kaunas). 2020 Feb 12;56(2):
pubmed: 32059426
Ann Hematol. 2013 Aug;92(8):1121-8
pubmed: 23604429
Patient Prefer Adherence. 2014 Apr 22;8:513-7
pubmed: 24790419
Hematology. 2018 Dec;23(10):817-822
pubmed: 29914346
Transfus Med Rev. 2015 Apr;29(2):90-101
pubmed: 25595476
Am J Med. 2018 Mar;131(3):319-322
pubmed: 29061498
Br J Haematol. 2018 May;181(3):331-340
pubmed: 29672840
Shock. 2020 Jun;53(6):701-709
pubmed: 31626037
Semin Dial. 2009 Sep-Oct;22(5):524-31
pubmed: 19558629
Crit Care Med. 2020 Apr;48(4):459-465
pubmed: 32205591
Nephrology (Carlton). 2017 Nov;22(11):838-847
pubmed: 28749067
Blood. 2019 Jun 6;133(23):2465-2477
pubmed: 30992265